🇺🇸 FDA
Patent

US 8680094

1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions

granted A61PA61P21/00A61P25/00

Quick answer

US patent 8680094 (1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions) held by The Board of Regents of the University of Texas System expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P21/00, A61P25/00, A61P25/08, A61P25/14